Please Wait
Applying Filters...
menu
    • menu
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Guanfacine HCl

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 4,714Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Neuraxpharm Boosts European ADHD Treatment With Tuzulby
    Neuraxpharm Boosts European ADHD Treatment With Tuzulby

    13 Jan 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-01-13/neuraxpharm-enhances-adhd-treatment-options-in-europe-with-launches-of-tuzulby-chewable-tablets-and-paxneury

    PHARMIWEB
    13 Jan 2026
    Share Share
    Wanbang Biopharms Generic Guanfacine Hydrochloride Receives Approval in US
    Wanbang Biopharms Generic Guanfacine Hydrochloride Receives Approval in US

    12 Jun 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217638

    FDA
    12 Jun 2024
    Share Share
    Xiromed`s Generic Guanfacine Hydrochloride Receives Approval in the U.S.
    Xiromed`s Generic Guanfacine Hydrochloride Receives Approval in the U.S.

    23 Feb 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218326

    FDA
    23 Feb 2024
    Share Share
    Health Canada Issues Recall of JAMP Guanfacine XR 1 mg: Foreign tablets
    Health Canada Issues Recall of JAMP Guanfacine XR 1 mg: Foreign tablets

    14 Dec 2023

    // HEALTH CANADA

    https://recalls-rappels.canada.ca/en/alert-recall/jamp-guanfacine-xr-1-mg-foreign-tablets

    HEALTH CANADA
    14 Dec 2023
    Share Share
    Alembic's Generic Guanfacine Hydrochloride Receives Approval in the U.S.
    Alembic's Generic Guanfacine Hydrochloride Receives Approval in the U.S.

    07 Aug 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217269

    FDA
    07 Aug 2023
    Share Share
    TWI Pharms`s Generic Guanfacine Hydrochloride Receives Approval in the US
    TWI Pharms`s Generic Guanfacine Hydrochloride Receives Approval in the US

    08 Jun 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216399

    FDA
    08 Jun 2022
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.